Infinity Natural Resources reported a significant increase in total revenues to $523.5 million for the nine months ended September 30, 2026, compared to $239.4 million in the prior year, driven by higher oil and gas sales. The company swung to a net income of $101.3 million for the period, up from a net loss of $16.4 million in 2025, despite a $72.0 million loss on derivative instruments. Significant activity included the $620.5 million Antero Acquisition and the issuance of $350 million in Series A Preferred Stock.
Trevi Therapeutics reported financial results for the third quarter of 2026, highlighting the initiation of its Phase 3 OCEAN-2 trial for IPF-related chronic cough. The company also reached alignment with the FDA on a Phase 2 development path for non-IPF ILD-related chronic cough, with a trial expected to start in Q1 2027. Trevi maintains a cash runway into 2030 to fund its key clinical milestones.
Term
Q3 2026
“This is an important time of clinical execution for Trevi as we actively open sites globally and enroll patients across all three active trials. We also recently aligned with the FDA on our non-IPF ILD-related chronic cough program and expect to initiate a Phase 2 dose-ranging trial in the first quarter of 2027.”
Jennifer Good, President and CEO of Trevi Therapeutics
Babcock & Wilcox reported Q3 2026 revenue of $291 million, a 109% year-over-year increase, driven by strong demand from utilities and data centers. The company reported net income of $94 million and reiterated its full-year 2026 Adjusted EBITDA guidance of $80 million to $105 million. Management highlighted a $16 billion global pipeline, including 6 gigawatts of opportunities in the data center market.
Term
Q3 2026
“B&W maintained its strong performance in the third quarter of 2026, reflecting continued demand across all of our businesses and sustained operational momentum. Rising global electricity demand is fueling increased needs from utilities, industrial and data center customers for our parts and services businesses and continues to drive new power generation opportunities.”
Kenneth Young, B&W's Chairman and Chief Executive Officer
“Our strong financial performance was underpinned by significant development in our bookings and backlog pipeline, setting the stage for continued growth in future quarters. During the third quarter, revenue and Adjusted EBITDA exceeded consensus street expectations and we continue to see positive momentum across our business.”
Kenneth Young, B&W's Chairman and Chief Executive Officer
Octave Specialty Group reported total assets of $2.30 billion as of September 30, 2026, with a notable increase in commissions revenue to $165.9 million for the first nine months of 2026 compared to $103.2 million in 2025. The company maintains a significant specialty property and casualty insurance presence, though it faces risks related to underwriting losses and stock price volatility.
Key Tronic reported a net loss of $7.5 million for the quarter ended September 26, 2026, compared to a $2.3 million loss in the prior year, driven by a significant decline in gross profit. Despite flat net sales of approximately $98.7 million, the company faced increased costs of sales and operating expenses, partially offset by a $3.2 million net gain from insurance proceeds.
Franklin Templeton reported a significant increase in fiscal year 2026 performance, with operating income rising 95% to $1.18 billion and total AUM growing 8% to $1.80 trillion. Growth was driven by $84.1 billion in long-term net inflows and $126.1 billion in market appreciation, despite $11.7 billion in net outflows at Western Asset Management.
Gladstone Investment Corporation reported financial results for its second fiscal quarter ended September 30, 2026, with total investment income of $24.2 million. The company reported net investment income of $4.8 million ($0.12 per share) and a net asset value per common share of $16.43. During the quarter, the company invested $156.5 million and maintained a portfolio of 31 companies.
Rackspace Technology reported Q3 2026 revenue of $609 million, a 9% year-over-year decrease, driven by a 17% decline in Public Cloud revenue despite 4% growth in Private Cloud. The company raised its full-year 2026 revenue outlook by $35 million at the midpoint while maintaining its profit and EBITDA guidance. Net loss for the quarter narrowed to $54 million compared to $67 million in the prior year period.
Term
Q3 2026
“This quarter we continued to execute on our business and financial plan and reaffirm our profit outlook for the full year while modestly increasing our revenue outlook.”
Gajen Kandiah, Chief Executive Officer
“As I enter my second year as CEO, we have moved from establishing our strategy to become the operator of the full enterprise AI stack and creating the framework to execute it, to now translating our go-to-market efforts and large existing capacity footprint into further commitments, rapid deployments and high margin operations.”
U.S. Physical Therapy hosted an earnings call to discuss its financial results for the third quarter and nine months ended September 30, 2026. The company reported record volume with 27 consecutive months of record visits and successfully transitioned its Metro New York facilities into the NYU Langone hospital partnership.
Term
Q3 2026
“With respect to visits, every month this year has been a record for that month. We are up to 27 consecutive months where that has occurred, nearly 2.5 years of record volume each and every month.”
P3 Health Partners reported Q3 2026 financial results with revenue of $396 million, up 15% year-over-year, and net income of $30.8 million. The company raised its full-year 2026 Adjusted EBITDA guidance midpoint to $100 million based on strong year-to-date performance and improved network economics.
Term
Q3 2026
“This was another strong quarter for P3. The foundation we have built over the past two years is showing up both in the care our patients receive and in the consistency of our results. We carry real momentum into 2027, as evidenced by our medical cost trend, and I am excited about what lies ahead for our patients, our providers, and our partners.”
Repay Holdings Corp reported a significant revenue increase to $153.4 million for Q3 2026, driven largely by the acquisition of KUBRA. Despite the growth, the company recorded a net loss of $10.4 million for the quarter, impacted by higher interest expenses and depreciation following the acquisition financing.
AAON, Inc. reported significant growth for the nine months ended September 30, 2026, with net sales increasing to $1.84 billion from $1.02 billion in the prior year period. Net income more than doubled to $172.5 million, driven by strong demand for its HVAC and data center cooling solutions, while the company maintained a solid balance sheet with total assets of $1.95 billion.
Senseonics reported total revenue of $19.6 million for the third quarter of 2026, a significant increase from $8.1 million in the prior year period. However, the company experienced a widening net loss of $101.7 million for the first nine months of 2026, driven by a substantial increase in selling, general, and administrative expenses.
Investors Title Company reported net income of $30.1 million for the nine months ended September 30, 2026, an increase from $27.7 million in the prior year period. Total revenues grew to $232.4 million, driven by higher net premiums written, although net income for the third quarter specifically decreased due to higher operating expenses and a significant increase in the provision for claims.
FutureFuel Corp. reported a significant revenue increase to $104.7 million for the third quarter of 2026, though it still incurred a net loss of $8.4 million. The company retrospectively adjusted its financial statements following a change in inventory accounting from LIFO to weighted average cost, and results were impacted by non-recurring costs from a winter storm and a tank farm fire.
Galaxy Digital reported net income of $322.8 million for the quarter ended September 30, 2026, a decrease from $505.1 million in the prior year period. Total assets grew significantly to $16.4 billion from $11.3 billion at year-end 2025, driven by increases in investments and property and equipment, while the company introduced new data center leasing revenue.
AbCellera reported Q3 2026 financial results with revenue of $10.6 million and a net loss of $40.8 million. The company highlighted positive Phase 2 data for its ABCL635 program and a $200 million capital raise that increased total liquidity to approximately $890 million.
Term
Q3 2026
“This was a transformative quarter for AbCellera, highlighted by strong clinical execution and balance sheet expansion. Positive top-line Phase 2 results for ABCL635 demonstrated an efficacy and tolerability profile that has potential to redefine the treatment of hot flashes.”
Carl Hansen, Ph.D., founder and CEO of AbCellera
“On the strength of this data, we raised $200 million, bringing our available liquidity to approximately $900 million. Together with the top-line Phase 1 readout of ABCL575 and the addition of three new pipeline programs, ABCL992, ABCL385, and ABCL646, we have delivered on all corporate priorities for 2026.”
Amneal Pharmaceuticals reported net revenue of $862.7 million for the third quarter of 2026, an increase from $784.5 million in the prior year period. Despite higher operating income, the company recorded a net loss attributable to Class A common stockholders of $21.7 million for the quarter, primarily due to accretion of redeemable non-controlling interests and acquisition-related costs.
For the nine months ended September 30, 2026, Lineage, Inc. reported flat net revenues of $4,019 million and a net loss of $256 million, compared to a $119 million loss in the prior year. The company's financial position shows total assets of $18,976 million and a significant increase in long-term debt to $6,813 million.
FutureFuel Corp. reported Q3 2026 total revenues of $104.7 million, a significant increase from the prior year, though it recorded a GAAP net loss of $8.4 million. Results were impacted by extended maintenance turnarounds in the chemicals segment and derivative losses in biofuels, despite robust biodiesel demand and multi-year high production volumes.
Term
Q3 2026
“Third quarter results reflected strong biodiesel demand and improved production economics, offset by extended maintenance on two dedicated chemicals production units that weighed on volumes, operating leverage and profitability in the period.”
Roeland Polet, Chairman and Chief Executive Officer
“Through early November, we have booked orders for more than 90% of our fourth quarter biodiesel production capacity, well ahead of prior expectations.”
Roeland Polet, Chairman and Chief Executive Officer
ArriVent BioPharma reported collaboration revenue of $5.0 million for the nine months ended September 30, 2026, compared to zero in the prior year. Despite this, the company saw a net loss of $133.5 million driven by $118.9 million in research and development expenses. Cash and short-term investments increased to $393.2 million, bolstered by $199.6 million in net proceeds from common stock issuances.
Quantum Corp reported a significant increase in total revenue to $89.6 million for the quarter ended September 30, 2026, compared to $62.7 million in the prior year. Despite improved gross profits, the company realized a net loss of $44.9 million for the quarter, primarily driven by a $51.6 million non-cash charge related to the change in fair value of warrant liabilities.
World Acceptance Corporation reported net income of $8.8 million for the quarter ended September 30, 2026, a significant improvement from a $1.7 million net loss in the prior year period. The company saw a decrease in the provision for credit losses and interest expense, while total revenues grew to $139.2 million.
AMCON Distributing Co. reports that cigarette distribution accounted for 64% of consolidated revenues and 17% of gross profit in fiscal 2026. The company faces significant risks from declining cigarette demand, increasing excise taxes, and intense competition from national wholesalers and online retailers utilizing AI and direct-to-business models.
Coherus Oncology reported Q3 2026 financial results, highlighted by $14.0 million in LOQTORZI net revenue. The company also announced a strategic prioritization plan focusing on tagmokitug for esophageal cancer and a 30% headcount reduction to lower quarterly cash burn.
Term
Q3 2026
“The strategic prioritization of esophageal cancer as our best-in-disease focus for tagmokitug, together with the Transition Services Agreement wind-down and the toripalimab process transfer completion, provides an ideal opportunity to right-size the organization and deliver financial benefits that flow directly from this prioritization”
Dennis M. Lanfear, Chief Executive Officer
“The financial benefits of right-sizing the organization and reducing the scope of our forward-focused efforts provide substantial and durable benefits to our operating model”
Aimco Operating Partnership transitioned to a liquidation basis of accounting on February 1, 2026, following the adoption of a Plan of Sale and Liquidation. As of September 30, 2026, the entity reported net assets in liquidation of $395.0 million, reflecting significant liquidating distributions to stockholders and noncontrolling interests during the period.
Aimco adopted a Plan of Sale and Liquidation in early 2026, transitioning its financial reporting from a going concern basis to a liquidation basis. As of September 30, 2026, the company reported net assets in liquidation of $395.0 million, having distributed $393.5 million to stockholders during the period.
Verde Clean Fuels reported a net loss of $6.3 million for the nine months ended September 30, 2026, an improvement from the $7.6 million loss in the prior year period. The company maintains a strong liquidity position with $52.6 million in cash and cash equivalents, while continuing to invest in its proprietary STG+ gas-to-liquids technology.
Infinity Natural Resources reported record third quarter 2026 results, with average daily production increasing 100% year-over-year to 431.7 MMcfe/d. The company generated record Adjusted EBITDAX of $137.7 million and is on track to exceed $25 million in synergies from its Antero acquisition. Management highlighted strong performance from acquired Ohio Utica assets and the completion of its first deep dry gas Utica well.
Term
Q3 2026
“Our third quarter results reflect a transition from integration to execution with record production and Adjusted EBITDAX. We laid out a clear set of strategic objectives and are demonstrating our ability to execute on those objectives. We delivered meaningful growth while funding nearly all of our capital program from operating cash flow.”
Zack Arnold, President and CEO
“Moving forward, our focus remains on organic and strategic growth, operational efficiency and maximizing the value of our assets. With a strong balance sheet, integrated midstream infrastructure, good visibility of our cash flow through our hedging program, and a deep inventory of development opportunities, Infinity is well positioned to navigate market conditions, and deliver sustainable long-term stockholder value.”
FreightCar America reported a net income of $11.6 million for the first nine months of 2026, a decrease from $54.7 million in the prior year period, primarily due to lower revenues and a significant gain in the fair market value of warrant liabilities. The company significantly improved its balance sheet by converting warrant liabilities into equity, resulting in a positive stockholders' equity of $36.3 million compared to a deficit in 2025.